Unió Europea - islandès - EMA (European Medicines Agency)

novartis europharm limited - ceritinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - zykadia er ætlað til meðferðar hjá fullorðnum sjúklingum með lungnakrabbamein (anaplastic lymphoma kinase (alk)) sem hefur áður fengið meðferð með crizotinibi.

Unió Europea - islandès - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamíð - blöðruhálskirtli - innkirtla meðferð - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Unió Europea - islandès - EMA (European Medicines Agency)

janssen-cilag international nv - apalutamide - blöðruhálskirtli - innkirtla meðferð - erleada er ætlað:í fullorðnir menn í meðferð ekki sjúklingum gelding þola krabbamein í blöðruhálskirtli (nmcrpc) sem eru á mikil hætta á að fá sjúklingum sjúkdómur. í fullorðnir menn fyrir meðferð af sjúklingum hormón-viðkvæm krabbamein í blöðruhálskirtli (mhspc) ásamt andrógen skort meðferð (adt).

Unió Europea - islandès - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Unió Europea - islandès - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - Æxlishemjandi lyf - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

Unió Europea - islandès - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Unió Europea - islandès - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 80 mg

Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 20 mg

Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

laboratorios normon s.a. - cyanocobalaminum inn - stungulyf, lausn - 1000 míkróg